TABLE 2

SURs of 18F-DTBZin Defined Regions of PD Patients and HCs

RegionHC (n = 17)PD (n = 30)PPercentage of decline
RN1.2 ± 0.31.1 ± 0.20.5208
C-Cau2.5 ± 0.41.6 ± 0.5<0.000136%
C-APu2.9 ± 0.51.2 ± 0.4<0.000159%
C-PPu2.8 ± 0.40.5 ± 0.2<0.000181%
C-SN1.1 ± 0.20.7 ± 0.2<0.000139%
C-HPC0.3 ± 0.10.3 ± 0.10.5724
C-AMG0.5 ± 0.10.5 ± 0.20.2362
C-NAc1.6 ± 0.70.8 ± 0.3<0.000147%
I-Cau2.4 ± 0.51.9 ± 0.50.001120%
I-APu2.9 ± 0.51.6 ± 0.5<0.000145%
I-PPu2.8 ± 0.50.9 ± 0.4<0.000167%
I-SN1.2 ± 0.30.8 ± 0.30.000131%
I-HPC0.3 ± 0.10.3 ± 0.10.8248
I-AMG0.5 ± 0.10.5 ± 0.20.3191
I-NAc1.6 ± 0.51.0 ± 0.50.000835%
C-DLPFC1.1 ± 0.10.9 ± 0.10.011918%
  • C (contralateral) = brain regions located opposite to symptomatic limbs (PD group) or right brain (HC group); I (ipsilateral) = brain regions located at side with clinical symptoms or left brain (HC group); DLPFC = dorsolateral prefrontal cortex.